Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro

Fig. 2

A negative correlation between BRCC3 expression and NPC patient survival. a Overall survival in NPC patients according to BRCC3 expression. Patients with high BRCC3 expression (n = 44) possessed with significantly poor overall survival compared with that of patients with low BRCC3 expression (n = 56) (P < 0.001). Number of patients at risk at 0, 3, 5, 10 years is shown below the survival curves (L, patients with low BRCC3 expression level; H, patients with high BRCC3 expression level). b Relapse Free Survival in NPC patients. The BRCC3 protein level was inversely correlated with nasopharyngeal carcinoma patient 3-year loco-regional relapse-free survival (P = 0.034)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us